Day 3 Highlights | ESC Congress 2019

Day 3 Highlights | ESC Congress 2019

10 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

 

Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease (AFIRE—0:35); effects of sacubitril-valsartan compared with enalapril on arterial hemodynamics and cardiac remodeling in patients with heart failure and reduced ejection fraction (EVALUATE-HF, PROVE-HF—4:39); using cardiolinguistics and artificial intelligence to reframe typical and atypical angina (HERMES—4:45), and the combined effect of lower LDL-C and lower systolic blood pressure on the lifetime risk of cardiovascular disease (LDL SBP—6:15). Visit https://www.acc.org/esc2019 for full meeting coverage.

Up next

Up Next Autoplay